Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Bunge Diverts Argentina Soybean Meal Ship Bound for China (Bloomberg) +++ BUNGE Aktie +3,10%

RESMED Aktie

 >RESMED Aktienkurs 
248.1 EUR    +1.0%    (Tradegate)
Ask: 248.3 EUR / 210 Stück
Bid: 247.8 EUR / 210 Stück
Tagesumsatz: 83 Stück
Realtime Kurs von 8 bis 22 Uhr!
RESMED Aktie über LYNX handeln
>RESMED Performance
1 Woche: +0,2%
1 Monat: +12,7%
3 Monate: +11,5%
6 Monate: +12,2%
1 Jahr: +23,0%
laufendes Jahr: +11,6%
>RESMED Aktie
Name:  RESMED INC. DL-,004
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US7611521078 / 895878
Symbol/ Ticker:  RME (Frankfurt) / RMD (NYSE)
Kürzel:  FRA:RME, ETR:RME, RME:GR, NYSE:RMD
Index:  S&P500
Webseite:  https://investor.resmed.c..
Profil:  ResMed Inc. is an innovative leader in the develop..
>Volltext..
Marktkapitalisierung:  35941.37 Mio. EUR
Unternehmenswert:  35626.88 Mio. EUR
Umsatz:  4416.52 Mio. EUR
EBITDA:  1650.47 Mio. EUR
Nettogewinn:  1202.08 Mio. EUR
Gewinn je Aktie:  8.19 EUR
Schulden:  731.02 Mio. EUR
Liquide Mittel:  1037.94 Mio. EUR
Operativer Cashflow:  1503.19 Mio. EUR
Bargeldquote:  1.2
Umsatzwachstum:  -0.13%
Gewinnwachstum:  24.75%
Dividende je Aktie:  1.96 EUR
Dividendenrendite:  0.74%
Dividendenschätzung:  0.84%
Div. Historie:  14.08.25 - 0.51228005€
08.05.25 - 0.47201797€
>weitere anzeigen...
Insiderhandel:  4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 3.837.463 USD.
Suchwörter:  RESMED
Letzte Datenerhebung:  21.08.25
>RESMED Kennzahlen
Aktien/ Unternehmen:
Aktien: 146.42 Mio. St.
Frei handelbar: 99.39%
Rückkaufquote: 0.54%
Mitarbeiter: 10600
Umsatz/Mitarb.: 0.42 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 3.38%
Bewertung:
KGV: 30.75
KGV lG: 26.42
KUV: 8.16
KBV: 7.17
PEG-Ratio: 0.8
EV/EBITDA: 21.59
Rentabilität:
Bruttomarge: 58.48%
Gewinnmarge: 27.22%
Operative Marge: 32.79%
Managementeffizenz:
Gesamtkaprendite: 18.62%
Eigenkaprendite: 25.86%
>RESMED Peer Group

Es sind 601 Aktien bekannt.
 
20.08.25 - 06:01
ResMed up on bullish analyst notes after solid quarter (Market Herald)
 
ResMed (ASX:RMD) is still batting eyelashes at brokers, with Ord Minnett reaffirming…...
20.08.25 - 00:12
Buy ResMed and this ASX stock for 10%+ returns (Fool)
 
Let's see what the broker is recommending to clients. The post Buy ResMed and this ASX stock for 10%+ returns appeared first on The Motley Fool Australia....
19.08.25 - 21:01
Insiderhandel: Aufsichtsrat verkauft Aktien von ResMed im Wert von 739289 USD (Insiderkauf)
 
Hernandez, John - Aufsichtsrat - Tag der Transaktion: 2025-08-18...
18.08.25 - 22:18
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio (GlobeNewswire EN)
 
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that board member Rich Sulpizio is thanked for two decades of contributions to Resmed, and will retire from the board, not standing for reelection at the 2025 Annual Meeting of Stockholders, scheduled for November 19, 2025....
13.08.25 - 23:42
XFRA: DIVIDEND/INTEREST INFORMATION - 14.08.2025 - US7611521078 (XETRA)
 
Das Instrument RME US7611521078 RESMED INC. DL-,004 EQUITY wird ex Dividende/Zinsen gehandelt am 14.08.2025 The instrument RME US7611521078 RESMED INC. DL-,004 EQUITY has its ex-dividend/interest day on 14.08.2025...
13.08.25 - 17:30
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term (Zacks)
 
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
11.08.25 - 20:01
Insiderhandel: Chief Executive Officer verkauft Aktien von ResMed im Wert von 2238379 USD (Insiderkauf)
 
Farrell, Michael J. - Vorstand - Tag der Transaktion: 2025-08-07...
11.08.25 - 17:30
Why ResMed (RMD) is a Top Growth Stock for the Long-Term (Zacks)
 
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
11.08.25 - 16:00
Here′s How Much You′d Have If You Invested $1000 in ResMed a Decade Ago (Zacks)
 
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....
06.08.25 - 21:36
ResMed is an ASX share market success story that deserves your attention (Fool)
 
This ASX share has made many investors wealthy over the past decade. The post ResMed is an ASX share market success story that deserves your attention appeared first on The Motley Fool Australia....
05.08.25 - 21:01
Insiderhandel: Chief Financial Officer verkauft Aktien von ResMed im Wert von 845700 USD (Insiderkauf)
 
Sandercock, Brett - Vorstand - Tag der Transaktion: 2025-08-01...
05.08.25 - 05:12
Why Austal, Credit Corp, EOS, and ResMed shares are racing higher today (Fool)
 
These shares are rising more than most today. But why? The post Why Austal, Credit Corp, EOS, and ResMed shares are racing higher today appeared first on The Motley Fool Australia....
05.08.25 - 05:01
Insiderhandel: Global General Counsel verkauft Aktien von ResMed im Wert von 14095 USD (Insiderkauf)
 
Rider, Michael J. - Vorstand - Tag der Transaktion: 2025-08-01...
05.08.25 - 03:00
What does Macquarie think Resmed shares are worth after its result? (Fool)
 
Resmed's share price is gaining momentum. The post What does Macquarie think Resmed shares are worth after its result? appeared first on The Motley Fool Australia....
05.08.25 - 01:36
ResMed share price is on watch for all-time highs (Fool)
 
Powered by rising margins, global growth, and confidence from management, this sleep tech stock is turning heads again. The post ResMed share price is on watch for all-time highs appeared first on The Motley Fool Australia....
05.08.25 - 01:36
ResMed RMD Q4 2025 Earnings Call Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
04.08.25 - 01:48
What does JP Morgan think Resmed shares are worth after reviewing its FY25 result? (Fool)
 
Resmed shares reached a new all-time high last Friday. The post What does JP Morgan think Resmed shares are worth after reviewing its FY25 result? appeared first on The Motley Fool Australia....
01.08.25 - 15:00
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb (Zacks)
 
RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand....
01.08.25 - 14:00
ResMed declares $0.60 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.08.25 - 06:42
Resmed Australia shares hit record high on strong earnings (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Nur übereilt bestimmt die Neigung sich. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!